Ching-Leou Teng
Chairman & Chief Pharmaceutical Officer
Company leadership profile.

PharmaEssentia Corporation, a biopharmaceutical company engages in medicine discovery, suppleme...
PharmaEssentia Corporation, a biopharmaceutical company engages in medicine discovery, supplements in developing specialty pharmaceutical reagents, API, and new drug patterns developments in the Americas, Europe, Asia, and Taiwan. Its products include BESREMi, an interferon therapy indicated for polycythemia vera, essential thrombocythemia, PMF, and adult T-cell leukemias. The company also develops Ropeg + anti PD-1; PEG-IL-2 (P11838); PEG-Cytokines; PD-1-IL-2v; ADC; ADCS; NY-ESO-1 TCR-T; and Novel TCR-T for the treatment of solid tumor and immunology. PharmaEssentia Corporation was founded in 1990 and is headquartered in Taipei, Taiwan.
Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.
Chairman & Chief Pharmaceutical Officer
Company leadership profile.
Founder, CEO, Chief Strategy Officer & Director
Company leadership profile.
President, GM & Director
Company leadership profile.
Chairperson of Japan
Company leadership profile.
Director
Company leadership profile.
Independent Director
Company leadership profile.
Independent Director
Company leadership profile.
Director
Company leadership profile.
Director
Company leadership profile.
Independent Director
Company leadership profile.
Independent Director
Company leadership profile.
1 expert evaluated PharmaEssentia.
Explore the public profiles of experts who have evaluated this project.
Orbitrum Academy